Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junhong Han

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Plos One|November 22, 2013
A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylationJayme L Dahlin, Rondedrick Sinville, Jonathan Solberg, et al.
Oncogene|June 20, 2026
SPOP-mediated nuclear ubiquitination degradation of p62/SQSTM1 contributes to HR repairXiaojuan Yang, Ying Zhou, Qing Huang, et al.
Journal of Translational Medicine|November 7, 2025
Multi-omics analyses identify mannose phosphate isomerase-centered hypoxia-induced angiogenesis signature in colorectal cancerSicheng Liu, Yang Zhang, Yang Meng, et al.
Nature Structural & Molecular Biology|October 27, 2009
Involvement of a chromatin remodeling complex in damage tolerance during DNA replicationKarina B Falbo, Constance Alabert, Yuki Katou, et al.
JCI Insight|June 10, 2025
MicroRNA-6084 orchestrates angiogenesis and liver metastasis in colorectal cancer via extracellular vesiclesYang Zhang, Xuyang Yang, Su Zhang, et al.
Clinical and Translational Medicine|December 29, 2021
Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcriptionMingtian Wei, Yaguang Zhang, Xuyang Yang, et al.
Oncogene|March 5, 2024
tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcriptionQunli Xiong, Yaguang Zhang, Yongfeng Xu, et al.
The Journal of Clinical Investigation|October 10, 2023
Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1Ming Zeng, Zizhi Tang, Laifeng Ren, et al.
Theranostics|August 15, 2019
Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagyZhe Zhang, Wei Gao, Li Zhou, et al.
Cell Reports|November 24, 2025
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53DTiantian Qin, Yi Ching Esther Wan, Shiman Hu, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Plos One|November 22, 2013
A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylationJayme L Dahlin, Rondedrick Sinville, Jonathan Solberg, et al.
Oncogene|June 20, 2026
SPOP-mediated nuclear ubiquitination degradation of p62/SQSTM1 contributes to HR repairXiaojuan Yang, Ying Zhou, Qing Huang, et al.
Journal of Translational Medicine|November 7, 2025
Multi-omics analyses identify mannose phosphate isomerase-centered hypoxia-induced angiogenesis signature in colorectal cancerSicheng Liu, Yang Zhang, Yang Meng, et al.
Nature Structural & Molecular Biology|October 27, 2009
Involvement of a chromatin remodeling complex in damage tolerance during DNA replicationKarina B Falbo, Constance Alabert, Yuki Katou, et al.
JCI Insight|June 10, 2025
MicroRNA-6084 orchestrates angiogenesis and liver metastasis in colorectal cancer via extracellular vesiclesYang Zhang, Xuyang Yang, Su Zhang, et al.
Clinical and Translational Medicine|December 29, 2021
Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcriptionMingtian Wei, Yaguang Zhang, Xuyang Yang, et al.
Oncogene|March 5, 2024
tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcriptionQunli Xiong, Yaguang Zhang, Yongfeng Xu, et al.
The Journal of Clinical Investigation|October 10, 2023
Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1Ming Zeng, Zizhi Tang, Laifeng Ren, et al.
Theranostics|August 15, 2019
Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagyZhe Zhang, Wei Gao, Li Zhou, et al.
Cell Reports|November 24, 2025
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53DTiantian Qin, Yi Ching Esther Wan, Shiman Hu, et al.
Pageof 9